enVVeno Medical (NVNO) October 2023 Investor Presentation - Venous Care

enVVeno Medical develops surgical and non-surgical replacement venous valves to treat Chronic Venous Insufficiency (CVI). The company is conducting the SAVVE U.S. pivotal trial for its VenoValve® and targeting deep venous CVI patients with a total addressable market of 2.5–3.5 million patients in the U.S.